Investigating how lack of ubiquitin affects B cell development and multiple myeloma
Functional Consequences of Ubiquitin Depletion During B Lymphocyte Differentiation
This study is looking at how a tiny protein called ubiquitin affects the development of immune cells called B lymphocytes, which are important for fighting infections, especially in people with multiple myeloma, a type of blood cancer. By understanding how losing ubiquitin impacts these cells, the researchers hope to find new ways to help improve treatments for this condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10897064 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of ubiquitin in the differentiation of B lymphocytes, which are crucial for immune function. It examines how the depletion of ubiquitin affects the survival and function of plasma cells, particularly in the context of multiple myeloma, a type of cancer. By utilizing advanced techniques like absolute mass spectrometry, the study aims to quantify ubiquitin levels during B cell differentiation and explore the relationship between ubiquitin depletion, immunoglobulin production, and cell death. The findings could provide insights into the molecular mechanisms underlying multiple myeloma and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple myeloma or those with related B cell malignancies.
Not a fit: Patients with non-B cell related cancers or those without any hematological malignancies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating multiple myeloma by targeting the mechanisms of B cell differentiation and survival.
How similar studies have performed: Previous research has shown promising results in understanding the role of ubiquitin in cell survival and cancer, indicating that this approach may yield valuable insights.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Bianchi, Giada — Brigham and Women's Hospital
- Study coordinator: Bianchi, Giada
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.